Astrazeneca Pharma India Limited(BSE:506820 NSE:ASTRAZEN) ,Company Snapshot, Recent Developments, Latest News, Financials, Price Charts, Ratios, Contact Information

Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals

Home

News Centre

IPO

Markets	Companies	Research	Industries	E-Mail Page

my Last 5 Scrips
Company	BSE Price(Rs)	% Chg
Ntpc Ltd	150.25	1.08
Tata Stl	313.15	4.56
State Ba	2151.15	1.15
Tata Mot	288.10	0.93
Hindalco	107.10	1.70
Clear All	Clear Last

NSE Live
Nifty Live Prices Live Quotes Top Gainers/Losers Top 10 Turnover No Delivery Stocks

BSE Live
BSE30 Live Prices Live Quotes Top Gainers/Losers Top 10 Turnover No Delivery Stocks

Market Pulse
Leaders Laggards FII Activity Mutual Fund Activity Meetings

Results Watch
Results Calendar Results Announced

IPO Watch

Company
Snapshots Quotes Charts Financials Recent News Broker Research Meetings Research Tutorial Discussion Forum

Research
Research Reports

Sector Watch

Economy Watch

Snapshot-Astrazeneca Pharma India Limited

Astrazeneca Pharma India Limited

Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:506820	NSE:ASTRAZEN	Bloomberg:ASTR@IN	Reuters:ASTR.BO
Market Lot: 1	Face Value: 2	ISIN Demat: INE203A01020

Quotes	Snapshot	Charts	Financials	Research	Recent News
Peer Group	AGM/AM	MF Holding	Discussion Forum	BSE/NSE Notices	BSE/NSE Deals

Recent Developments
06-MAR-13 AstraZeneca Pharma India announced that the company received by e-mail communication a scanned copy of the letter from the promoter shareholder of the company, AstraZeneca Pharmaceuticals AB Sweden notifying the its decision to reduce its shareholding in the company in order to comply with the requirement of minimum public shareholding, to receipt of all necessary statutory and regulatory approvals, as may be required, appropriate mar... More..
Business Profile	Future Plans

One To One

Latest News

AstraZeneca bounces back from early loss -IRIS 06-Mar-13

Brief Financials (in Rs. Mn.)

Period ending (months)	31-Dec-2012(9)	31-Mar-2012 (12)	31-Mar-2011 (15)
Net sales	2954.03	5312.80	5743.62
Other Income	97.90	63.30	62.81
Total Income	3051.93	5376.10	5806.43
Cost of goods sold	3501.95	5012.57	4905.08
OPBDIT	-450.02	363.53	901.35
PAT	-709.57	197.65	641.30
Gross Block	-	-	-
Equity capital	50.00	50.00	50.00
EPS (Rs.)	-	7.91	0.00
DPS (Rs.)	-	-	-
BV (Rs.)	-	-	-
P/E range (x)	-	146.90 - 314.66	NA
Debt / Equity (x)	-	-	-
Operating margin (% of OI)	-14.7	6.8	15.5
Net margin (% of OI)	-23.2	3.7	11.0